-
公开(公告)号：US20180306826A1
公开(公告)日：2018-10-25
申请号：US15496407
申请日：2017-04-25
Applicant: David R. Hall , Dan Allen , Conrad Rosenbrock , Daniel Hendricks , Andrew Nguyen , Steven J.M. Butala , Travis Niederhauser , Terrece Pearman , Joe Fox
Inventor： David R. Hall , Dan Allen , Conrad Rosenbrock , Daniel Hendricks , Andrew Nguyen , Steven J.M. Butala , Travis Niederhauser , Terrece Pearman , Joe Fox
CPC classification number: G01N33/94 , A47K17/00 , A61B5/15 , A61B10/0038 , A61B10/0051 , A61B10/007 , A61B2010/0061 , A61B2010/0077 , A61B2010/0087 , G01N33/15 , G01N33/493 , G01N2458/00
Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, moisture, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.
-
公开(公告)号：US20200297310A1
公开(公告)日：2020-09-24
申请号：US16360708
申请日：2019-03-21
Applicant: David R. Hall , K. Jeffrey Campbell , Joshua Larsen , Jared Reynolds , Daniel Hendricks , Travis Niederhauser , Steven J.M. Butala , Joshua D. Heiner , A. Terrece Pearman , Vivek Garg
Inventor： David R. Hall , K. Jeffrey Campbell , Joshua Larsen , Jared Reynolds , Daniel Hendricks , Travis Niederhauser , Steven J.M. Butala , Joshua D. Heiner , A. Terrece Pearman , Vivek Garg
Abstract: The medical toilet may include a seat, lid, and bowl as does a traditional toilet. It also includes one or more acoustic transducers. The acoustic transducers may be located on the seat where they may measure bone density in a user's pelvis or femur. The acoustic transducers may be located on the lid or on a belt which wraps around the user. These acoustic transducers may collect data relating to a user's heart, lungs, liver, bowel, or other internal organs. The medical toilet may include a handrail with an acoustic transducer which measures the bone density in the user's wrist, radius, or ulna. A controller associated with the medical toilet may store algorithms for analyzing the data collected by the acoustic transducers. The controller may perform machine learning to improve the analyses and may calculate trends in repeated measurements taken from the same user or a population of users.
-
公开(公告)号：US10407888B2
公开(公告)日：2019-09-10
申请号：US15862091
申请日：2018-01-04
Applicant: David R. Hall , Travis Niederhauser , Jared Reynolds , Joshua Larsen , Ben Swenson , Clayton Jorgensen , Andrew Nguyen , Terrece Pearman , Daniel Hendricks
Inventor： David R. Hall , Travis Niederhauser , Jared Reynolds , Joshua Larsen , Ben Swenson , Clayton Jorgensen , Andrew Nguyen , Terrece Pearman , Daniel Hendricks
Abstract: The bidet system may include multiple seat scales which may float between the toilet bowl rim and the toilet seat. These seat scales may collect measurements which are transmitted to a controller. The controller may include instructions to calculate a user's center of mass based on the measurements and to identify the position of the user's anus based on the center of mass. The controller may then transmit instructions to a bidet wand directing direct the bidet wand to a position which aims a cleansing fluid spray toward the user's anus. A camera which collects images of the user's anal and urogenital region may also be included in the bidet system. The camera may transmit obfuscated images to the controller to identify other areas of the user's anatomy in need of cleansing. The controller may direct the bidet wand to aim a cleansing fluid spray toward these areas.
-
公开(公告)号：US20180335427A1
公开(公告)日：2018-11-22
申请号：US15601532
申请日：2017-05-22
Applicant: David R. Hall , Steven J.M. Butala , Dan Allen , Andrew Nguyen , Conrad Rosenbrock , Ben Swenson , Daniel Hendricks , Travis Niederhauser , Terrece Pearman , Joe Fox
Inventor： David R. Hall , Steven J.M. Butala , Dan Allen , Andrew Nguyen , Conrad Rosenbrock , Ben Swenson , Daniel Hendricks , Travis Niederhauser , Terrece Pearman , Joe Fox
IPC: G01N33/543 , C12Q1/68 , G01N33/94
Abstract: We disclose a tag for tracking and identifying pharmaceutical and nutritional products. The tag includes a paramagnetic microparticle which is connected to at least one unique and detectable chemical. The chemical may be coated on the paramagnetic microparticle or connected through functional groups. The tags may be too large to be taken into the bloodstream and therefore remain in the user's gastrointestinal tract. The tags may be fully or partially isolated from feces for analysis. The tags are attracted to an external electromagnetic force but are not magnetically attracted to each other. Consequently, the tags are safe to ingest. The tags may vary in volume or mass so as to be separable according to mass. The tags may be non-spherical in shape thus increasing the surface area to volume ratio and increasing the amount of chemical which may be attached as a taggant.
-
公开(公告)号：US20180306825A1
公开(公告)日：2018-10-25
申请号：US15494089
申请日：2017-04-21
Applicant: David R. Hall , Dan Allen , Conrad Rosenbrock , Daniel Hendricks , Andrew Nguyen , Steven J.M. Butala , Travis Niederhauser , Terrece Pearman , Joe Fox
Inventor： David R. Hall , Dan Allen , Conrad Rosenbrock , Daniel Hendricks , Andrew Nguyen , Steven J.M. Butala , Travis Niederhauser , Terrece Pearman , Joe Fox
CPC classification number: G01N33/94 , A61B10/0038 , A61B10/0051 , A61B10/007 , A61B2010/0061 , A61B2010/0077 , G01N33/15 , G01N33/493 , G01N33/58
Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.
-
Patent Agency Ranking
6.发明申请公开(公告)号：US20200253480A1
公开(公告)日：2020-08-13
申请号：US16272206
申请日：2019-02-11
Applicant: David R. Hall , Joshua Larsen , Jared Reynolds , Daniel Hendricks , Travis Niederhauser , K. Jeffrey Campbell , Steven J.M. Butala , Vivek Garg
Inventor： David R. Hall , Joshua Larsen , Jared Reynolds , Daniel Hendricks , Travis Niederhauser , K. Jeffrey Campbell , Steven J.M. Butala , Vivek Garg
Abstract: The sensor platform array includes a plurality of sensors and one or more sensor platforms. Each sensor may be mounted on a sensor platform. The sensor platform may be mounted on a support panel. The support panel may be mounted on a toilet lid. The one or more sensor platforms may be extendable towards a user seated on the toilet. Each sensor may be independently extended so that it is positioned flush against a user's body. The sensor platform array may include bendable arms which reach around a user and place sensors on the ventral side of the user. The sensors may collect measurements which are relevant to the user's health and well-being. In some embodiments, the sensors may be removable and replaceable so that different sensors may be added according to a user's individual needs.
-
公开(公告)号：US10408849B2
公开(公告)日：2019-09-10
申请号：US15494089
申请日：2017-04-21
Applicant: David R. Hall , Dan Allen , Conrad Rosenbrock , Daniel Hendricks , Andrew Nguyen , Steven J. M. Butala , Travis Niederhauser , Terrece Pearman , Joe Fox
Inventor： David R. Hall , Dan Allen , Conrad Rosenbrock , Daniel Hendricks , Andrew Nguyen , Steven J. M. Butala , Travis Niederhauser , Terrece Pearman , Joe Fox
Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.
-
公开(公告)号：US20200289048A1
公开(公告)日：2020-09-17
申请号：US16352130
申请日：2019-03-13
Applicant: David R. Hall , Joshua Larsen , Jared Reynolds , K. Jeffrey Campbell , Travis Niederhauser , Daniel Hendricks , Steven J.M. Butala , Vivek Garg
Inventor： David R. Hall , Joshua Larsen , Jared Reynolds , K. Jeffrey Campbell , Travis Niederhauser , Daniel Hendricks , Steven J.M. Butala , Vivek Garg
Abstract: The medical toilet includes one or more sensors for measuring hardness of a soft tissue in contact with the sensor. The one or more sensors may be positioned on the toilet seat, toilet lid, or on a foot scale which extends from the base of the medical toilet. The sensors may include durometers, fluid-filled bubbles with pressure sensors on them, or an inflatable tube with pressure sensors on it. The measurements may be transmitted to a controller which may store and analyze the data. Changes in tissue hardness over time may be tracked and reported. The sensors may identify changes in the hardness of skin, adipose tissue, and muscle. These measurements may be useful to identify changes in skin thickness, body fat, muscle tone, tumors and other masses.
-
公开(公告)号：US10722120B1
公开(公告)日：2020-07-28
申请号：US16272206
申请日：2019-02-11
Applicant: David R. Hall , Joshua Larsen , Jared Reynolds , Daniel Hendricks , Travis Niederhauser , K. Jeffrey Campbell , Steven J. M. Butala , Vivek Garg
Inventor： David R. Hall , Joshua Larsen , Jared Reynolds , Daniel Hendricks , Travis Niederhauser , K. Jeffrey Campbell , Steven J. M. Butala , Vivek Garg
Abstract: The sensor platform array includes a plurality of sensors and one or more sensor platforms. Each sensor may be mounted on a sensor platform. The sensor platform may be mounted on a support panel. The support panel may be mounted on a toilet lid. The one or more sensor platforms may be extendable towards a user seated on the toilet. Each sensor may be independently extended so that it is positioned flush against a user's body. The sensor platform array may include bendable arms which reach around a user and place sensors on the ventral side of the user. The sensors may collect measurements which are relevant to the user's health and well-being. In some embodiments, the sensors may be removable and replaceable so that different sensors may be added according to a user's individual needs.
-
10.发明申请公开(公告)号：US20180313805A1
公开(公告)日：2018-11-01
申请号：US15497501
申请日：2017-04-26
Applicant: David R. Hall , Dan Allen , Conrad Rosenbrock , Daniel Hendricks , Andrew Nguyen , Steven J.M. Butala , Travis Niederhauser , Joe Fox , Terrece Pearman
Inventor： David R. Hall , Dan Allen , Conrad Rosenbrock , Daniel Hendricks , Andrew Nguyen , Steven J.M. Butala , Travis Niederhauser , Joe Fox , Terrece Pearman
Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition has decayed in response to environmental conditions and time. The taggants may decay in response to environmental conditions which cause drugs to lose their efficacy. The decay may occur due to improper storage or excursions into certain environmental conditions. These environmental conditions may include light, temperature, moisture, oxidation, and age. By including taggants that have different decay characteristics, the environmental condition that caused the decay may be determined. The amount of time the drug composition was exposed to the environmental condition and the amount of effective drug remaining may also be determined. The disclosed method may reduce the need for a unique assay for each drug to assess decay and determine shelf life. The disclosed method may also be used as a quality control technique for pharmaceutical products.
-
-
-
-
-
-
-
-
-
Search Results
18
records
(took 0.143 seconds)
